相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
Alexandros A. Polymeris et al.
ANNALS OF NEUROLOGY (2022)
Differences between Atrial Fibrillation Detected before and after Stroke and TIA: A Systematic Review and Meta-Analysis
Sebastian Fridman et al.
CEREBROVASCULAR DISEASES (2022)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Insights Into Direct Oral Anticoagulant Therapy Implementation of Stroke Survivors with Atrial Fibrillation in an Ambulatory Setting
Valerie Albert et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)
Oral Anticoagulants in Atrial Fibrillation Patients With Recent Stroke Who Are Dependent on the Daily Help of Others
Louisa Meya et al.
STROKE (2021)
Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP-AF trial
Tsuyoshi Shiga et al.
JOURNAL OF ARRHYTHMIA (2021)
Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
David J. Seiffge et al.
ANNALS OF NEUROLOGY (2020)
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
Ole-Christian W. Rutherford et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation The NAXOS Study
Eric Van Ganse et al.
STROKE (2020)
Small vessel disease is associated with an unfavourable outcome in stroke patients on oral anticoagulation
Lisa Hert et al.
EUROPEAN STROKE JOURNAL (2020)
Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation
David J. Seiffge et al.
ANNALS OF NEUROLOGY (2019)
Real-world adherence for direct oral anticoagulants in anewly diagnosed atrial fibrillation cohort: does the dosing interval matter?
Phuong N. Pham et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation
David J. Graham et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
David J. Seiffge et al.
LANCET NEUROLOGY (2019)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Catharina J. M. Klijn et al.
EUROPEAN STROKE JOURNAL (2019)
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
L. Staerk et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study -
Sohei Yoshimura et al.
CIRCULATION JOURNAL (2018)
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Gregory Y. H. Lip et al.
STROKE (2018)
Strengths and weaknesses of 'realworld' studies involving non-vitamin K antagonist oral anticoagulants
A. John Camm et al.
OPEN HEART (2018)
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis
George Ntaios et al.
STROKE (2017)
Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke
Daniela Rohde et al.
PLOS ONE (2017)
Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
Peter A. Noseworthy et al.
CHEST (2016)
Frequency and Determinants of Adherence to Oral Anticoagulants in Stroke Patients with Atrial Fibrillation in Clinical Practice
Alexandros A. Polymeris et al.
EUROPEAN NEUROLOGY (2016)
Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke
Mark J. Alberts et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Early start of DOAC after ischemic stroke Risk of intracranial hemorrhage and recurrent events
David J. Seiffge et al.
NEUROLOGY (2016)
Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses
Sukainah Al AlShaikh et al.
EUROPEAN STROKE JOURNAL (2016)
Intracranial Hemorrhage After Ischemic Stroke Incidence, Time Trends, and Predictors in a Swedish Nationwide Cohort of 196765 Patients
Joachim Ogren et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
Colleen A. McHorney et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence
Bernard Vrijens et al.
EUROPACE (2015)
Intracranial Hemorrhage After Ischemic Stroke Incidence, Time Trends, and Predictors in a Swedish Nationwide Cohort of 196765 Patients
Joachim Ogren et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria
Andreas Clemens et al.
PLOS ONE (2014)
Eligibility and Preference of New Oral Anticoagulants in Patients With Atrial Fibrillation Comparison Between Patients With Versus Without Stroke
Chang Hyo Yoon et al.
STROKE (2014)
Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?
R. A. Rodriguez et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
分享论文
